methamphetamine has been researched along with Alzheimer Disease in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 7 (70.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Hu, M; Tang, J; Tao, L; Wang, J; Wang, X; Zhang, X; Zhang, Y | 1 |
| Boontor, A; Govitrapong, P; Nopparat, C; Panmanee, J | 1 |
| Shukla, M; Vincent, B | 1 |
| Jang, WJ; Jeong, CH; Lee, S; Ryu, IS; Son, T; Song, SH | 1 |
| Alabed, S; Chang, SL; Sariyer, IK; Zhou, H | 1 |
| Govitrapong, P; Namyen, J; Nopparat, C; Panmak, P; Permpoonpattana, K | 1 |
| Dehghan Shasaltaneh, M; Masoudian, N; Riazi, GH; Soltanian, B | 1 |
| Chen, L; Fang, F; Fei, J; Jiang, L; Wang, J; Xiao, H; Yu, P; Zhou, L | 1 |
| Huang, SH; Jong, A; Li, L; Liu, L; Mao, DA; Wu, CH; Yu, J; Zhang, B | 1 |
| Dickerson, TJ; Janda, KD; Treweek, JB | 1 |
2 review(s) available for methamphetamine and Alzheimer Disease
| Article | Year |
|---|---|
The multi-faceted impact of methamphetamine on Alzheimer's disease: From a triggering role to a possible therapeutic use.
Topics: Aging; Alzheimer Disease; Brain; Central Nervous System Stimulants; Humans; Methamphetamine | 2020 |
Meta-Analysis of Methamphetamine Modulation on Amyloid Precursor Protein through HMGB1 in Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Central Nervous System Stimulants; HMGB1 Protein; Humans; Methamphetamine; Protein Interaction Maps; Signal Transduction | 2021 |
8 other study(ies) available for methamphetamine and Alzheimer Disease
| Article | Year |
|---|---|
Methamphetamine-mediated dissemination of β-amyloid: Disturbances in endocytosis, transport and clearance of β-amyloid in microglial BV2 cells.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Endocytosis; Humans; Methamphetamine; Microglia; Neurodegenerative Diseases; Peptide Fragments | 2022 |
Melatonin Attenuates Methamphetamine-Induced Alteration of Amyloid β Precursor Protein Cleaving Enzyme Expressions via Melatonin Receptor in Human Neuroblastoma Cells.
Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Humans; Melatonin; Methamphetamine; Neuroblastoma; Neurodegenerative Diseases; Receptors, Melatonin | 2022 |
Transcriptional Profiling of Whisker Follicles and of the Striatum in Methamphetamine Self-Administered Rats.
Topics: Alzheimer Disease; Amphetamine-Related Disorders; Animals; Corpus Striatum; Disease Models, Animal; Gene Expression Regulation; Hair Follicle; High-Throughput Nucleotide Sequencing; Humans; Huntington Disease; Methamphetamine; Neostriatum; Parkinson Disease; Rats; Self Administration; Signal Transduction; Transcriptome; Vibrissae | 2020 |
Melatonin protects against methamphetamine-induced Alzheimer's disease-like pathological changes in rat hippocampus.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Central Nervous System Stimulants; Cognitive Dysfunction; Hippocampus; Learning Disabilities; Male; Maze Learning; Melatonin; Memory Disorders; Methamphetamine; Neuroprotective Agents; Rats; Rats, Wistar | 2021 |
Alteration of gene expression in reactive astrocytes induced by Aβ1-42 using low dose of methamphetamine.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Apoptosis; Astrocytes; bcl-2-Associated X Protein; bcl-X Protein; Brain; Central Nervous System; Cyclin-Dependent Kinase 5; Gene Expression; Glycogen Synthase Kinase 3 beta; Hippocampus; Humans; Methamphetamine; Neurons; Peptide Fragments; Protein Kinase C-alpha; Transcriptome | 2021 |
Methamphetamine exposure upregulates the amyloid precursor protein and hyperphosphorylated tau expression: The roles of insulin signaling in SH-SY5Y cell line.
Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Cell Line, Tumor; Central Nervous System Stimulants; Extracellular Signal-Regulated MAP Kinases; Gene Expression; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Insulin; Methamphetamine; Phosphorylation; Proto-Oncogene Proteins c-akt; Signal Transduction; tau Proteins | 2019 |
Alpha7 nicotinic acetylcholine receptor is required for amyloid pathology in brain endothelial cells induced by Glycoprotein 120, methamphetamine and nicotine.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Animals; Biomarkers; Blood-Brain Barrier; Brain; Cell Movement; Cellular Senescence; Endothelial Cells; HIV Envelope Protein gp120; HL-60 Cells; Humans; Methamphetamine; Mice, Inbred C57BL; Monocytes; Nicotine; Protein Transport; Receptor for Advanced Glycation End Products; S100 Proteins; Time Factors | 2017 |
Drugs of abuse that mediate advanced glycation end product formation: a chemical link to disease pathology.
Topics: Alzheimer Disease; Atherosclerosis; Diabetes Mellitus; Disease; Glycation End Products, Advanced; Humans; Macular Degeneration; Methamphetamine; Molecular Structure; Neoplasms; Nicotine | 2009 |